<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03143465</url>
  </required_header>
  <id_info>
    <org_study_id>H-15019063</org_study_id>
    <nct_id>NCT03143465</nct_id>
  </id_info>
  <brief_title>Pharmacologically Triggered Migraine Without Aura and Neuroimaging</brief_title>
  <sponsors>
    <lead_sponsor>
      <agency>Danish Headache Center</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Danish Headache Center</source>
  <brief_summary>
    <textblock>
      Migraine is a highly disabling disorder affecting 14% of the general population Worldwide and
      ranked as the 6th most debilitating disease worldwide by the WHO. One of the most fundamental
      questions of migraine, which remains to be elucidated, is the mechanism behind the generation
      of migraine attacks.

      We will use calcitonin gene-related peptide (CGRP) and sildenafil as pharmacological triggers
      of migraine, combined with advanced neuroimaging techniques, to investigate the attack
      initiating pathophysiology.

      Both substances have previously been administered to healthy participants and migraine
      without aura patients, inducing headache and migraine-like-attacks.

      We hope to contribute with novelty to the current understanding of the migraine
      pathophysiology and development of more efficient treatment of migraine.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">August 2016</start_date>
  <completion_date type="Anticipated">December 2018</completion_date>
  <primary_completion_date type="Anticipated">December 2018</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <primary_purpose>Basic Science</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
    <masking_description>Double Blind</masking_description>
  </study_design_info>
  <primary_outcome>
    <measure>CGRP and sildenafil induced MRI-changes</measure>
    <time_frame>0-6h</time_frame>
    <description>CGRP and sildenafil induced MRI-changes</description>
  </primary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Anticipated">36</enrollment>
  <condition>Migraine With Aura</condition>
  <arm_group>
    <arm_group_label>CGRP</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Sildenafil</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Placebo</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Calcitonin Gene-Related Peptide</intervention_name>
    <arm_group_label>CGRP</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Sildenafil</intervention_name>
    <arm_group_label>Sildenafil</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Placebo</intervention_name>
    <arm_group_label>Placebo</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Age between 18 and 50 years

          -  Weight: 50-100 kg

          -  Diagnosis of migraine without aura (patient group only)

          -  Attacks of migraine without aura at least once every second month (patient group only)

          -  Unilateral headache (patient group only)

          -  Use of safe contraception (women of fertile age only)

        Exclusion Criteria:

          -  History or family history of migraine (healthy subject group only)

          -  Tension-type headache more than one day per month on average (healthy subject group
             only)

          -  Any other primary headache disorder

          -  Daily intake of medication

          -  Pregnant or breastfeeding women

          -  Headache 48 h prior to study day

          -  Hypertension on the study day (systolic BP&gt;150 mmHg or diastolic BP&gt; 100 mmHg)

          -  Hypotension on the study day (systolic BP&lt;90 mmHg or diastolic BP&lt;50 mmHg)

          -  History of any cardiovascular disease including cerebrovascular disease

          -  Any disorder, that is deemed ineligble for participation by the study physicians

          -  Contraindications of MRI
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>50 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Samaira Younis</last_name>
    <phone>+4538632176</phone>
    <email>samaira.younis.01@regionh.dk</email>
  </overall_contact>
  <location>
    <facility>
      <name>Danish Headache Center, University Hospital</name>
      <address>
        <city>Glostrup</city>
        <country>Denmark</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Samaira Younis</last_name>
    </contact>
  </location>
  <location_countries>
    <country>Denmark</country>
  </location_countries>
  <verification_date>May 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>May 4, 2017</study_first_submitted>
  <study_first_submitted_qc>May 4, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">May 8, 2017</study_first_posted>
  <last_update_submitted>May 4, 2017</last_update_submitted>
  <last_update_submitted_qc>May 4, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">May 8, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Danish Headache Center</investigator_affiliation>
    <investigator_full_name>Samaira Younis</investigator_full_name>
    <investigator_title>MD</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Migraine Disorders</mesh_term>
    <mesh_term>Migraine with Aura</mesh_term>
    <mesh_term>Migraine without Aura</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Sildenafil Citrate</mesh_term>
    <mesh_term>Calcitonin Gene-Related Peptide</mesh_term>
    <mesh_term>Calcitonin</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

